Barclays initiated or updated coverage on Intellia Therapeutics (NTLA) with a price target of $8.00 per share, according to a ratings note.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
